Biology

Why is important to pay attention to cognition in multiple sclerosis? 3:20
Why is important to pay attention to cognition in multiple sclerosis?
Claire Riley • 26 Feb 2021
Determining the optimal treatment strategy in MS 4:18
Determining the optimal treatment strategy in MS
Tanuja Chitnis • 23 Feb 2021
Autoimmune encephalitis: understanding prevalence and pathogenesis 2:16
Autoimmune encephalitis: understanding prevalence and pathogenesis
Divyanshu Dubey • 15 Feb 2021
DMT use and clinical characteristics in MS by race and ethnicity 1:39
DMT use and clinical characteristics in MS by race and ethnicity
Carlos Pérez • 25 Feb 2021
Are COVID-19 vaccines safe and effective in the setting of MS DMTs? 4:06
Are COVID-19 vaccines safe and effective in the setting of MS DMTs?
Amit Bar-Or • 25 Feb 2021
The demographics of MS in Latin America 1:33
The demographics of MS in Latin America
Fernando Hamuy Diaz de Bedoya • 15 Feb 2021
Estrogen treatments to negate menopausal effects on disability severity in women with MS 6:12
Estrogen treatments to negate menopausal effects on disability severity in women with MS
Rhonda Voskuhl • 25 Feb 2021
Serum neurofilament light chain levels as a biomarker in MS 4:48
Serum neurofilament light chain levels as a biomarker in MS
Elias Sotirchos • 23 Feb 2021
Determining the optimal treatment strategy in MS 4:18
Determining the optimal treatment strategy in MS
Tanuja Chitnis • 23 Feb 2021
Changing approaches to cognitive assessment in MS 1:37
Changing approaches to cognitive assessment in MS
Tanuja Chitnis • 23 Feb 2021
Ensemble learning methods predict disease course in MS 2:26
Ensemble learning methods predict disease course in MS
Tanuja Chitnis • 23 Feb 2021
Diagnostic biomarkers and efficacious treatments are unmet needs in autoimmune encephalitis 1:45
Diagnostic biomarkers and efficacious treatments are unmet needs in autoimmune encephalitis
Divyanshu Dubey • 15 Feb 2021
The impact of social networks on physical impairment in MS 1:34
The impact of social networks on physical impairment in MS
Dalia Rotstein • 16 Feb 2021
Serum neurofilament levels are associated with health outcomes and resource use in MS 1:34
Serum neurofilament levels are associated with health outcomes and resource use in MS
Tanuja Chitnis • 23 Feb 2021
Paraneoplastic etiology of myeloneuropathy 1:47
Paraneoplastic etiology of myeloneuropathy
Divyanshu Dubey • 15 Jan 2021
Assessing novel biomarkers: retinal layer atrophy in PMS vs. RRMS 2:28
Assessing novel biomarkers: retinal layer atrophy in PMS vs. RRMS
Elias Sotirchos • 23 Feb 2021
The content of VJNeurology is intended for healthcare professionals